Even as patents on huge blockbuster drugs are still expiring, the smart generics companies have been preparing for some time for a future in which there are fewer and fewer syntehsized molecules to copy and …

Following the death of Mr. Merckle, the sale of his empire continues at a swift pace. The Independent is reporting that Phoenix UK, with a turnover of €1.2bn and controlling 15 per cent of the …

The first generics casualty of the financial crisis was Ratiopharm which is now being sold my the Merckle family to make up for their recent stock market losses. Now Actavis, the fifth largest generics company …

We were shocked today to read that the owner of both Ratiopharm, one of Europe’s largest generics companies and Phoenix PharmaHandel, Europe’s 2nd largest drug distributor, has committed suicide as a result of having lost …